Hecogenin
(Synonyms: 海柯吉宁; (+)-Hecogenin; NSC 115921) 目录号 : GC38428A steroid sapogenin with diverse biological activities
Cas No.:467-55-0
Sample solution is provided at 25 µL, 10mM.
Hecogenin is a natural steroid sapogenin with diverse biological activities that was originally isolated from A. sisalana and has been used in the synthesis of steroids.1 It has antioxidant, anti-inflammatory, antiproliferative, and neuroprotective properties.2,3,4,5 Hecogenin (10 μM) decreases superoxide anion formation induced by N-Formyl-Met-Leu-Phe in rat neutrophils by 23.6%.2 It also inhibits myeloperoxidase (MPO) release from human neutrophils activated by phorbol 12-myristate 13-acetate when used at a concentration of 1 μg/ml.3 Hecogenin inhibits proliferation of the breast cancer cell lines MDA-MB-231, MDA-MB-468, MCF-10A, MCF-7, T47D, BT474, and SK-BR-3 (IC50s = 28.7-38.2 μM).4 It decreases the number of glutamate-induced TUNEL-positive primary rat spinal motor neurons by 11% when used at a concentration of 1 μM.5 In vivo, hecogenin (15 mg/kg) decreases the mucosal lesion area of ethanol-induced gastric ulceration in mice.3 It also decreases tumor volume in an MDA-MB-231 human breast cancer mouse xenograft model when administered at a dose of 10 mg/kg three times per week.4
1.Cripps, A.L., and Blunden, G.A quantitative gas-liquid chromatographic method for the estimation of hecogenin and tigogenin in the leaves, juice and sapogenin concentrates of Agave sisalanaSteroids31(5)661-669(1978) 2.Tsai, P.L., Wang, J.P., Chang, C.W., et al.Constituents and bioactive principles of Polygonum chinensisPhytochemistry49(6)1663-1666(1998) 3.Santos Cerqueira, G., dos Santos e Silva, G., Rios Vasconcelos, E., et al.Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in miceEur. J. Pharmacol.683(1-3)260-269(2012) 4.Elsayed, H.E., Ebrahim, H.Y., Haggag, E.G., et al.Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignanciesBioorg. Med. Chem.25(24)6297-6312(2017) 5.Vincent, A.M., Backus, C., Taubman, A.A., et al.Identification of candidate drugs for the treatment of ALSAmyotroph. Lateral Scler. Other Motor Neuron Disord.6(1)29-36(2005)
Cas No. | 467-55-0 | SDF | |
别名 | 海柯吉宁; (+)-Hecogenin; NSC 115921 | ||
Canonical SMILES | [H][C@]1(O[C@@]2(OC[C@H](C)CC2)[C@@H](C)[C@@]1([C@]34C)[H])C[C@@]3([H])[C@]5([H])CC[C@@]6([H])C[C@@H](O)CC[C@]6(C)[C@@]5([H])CC4=O | ||
分子式 | C27H42O4 | 分子量 | 430.62 |
溶解度 | DMF: 30 mg/ml, 0.8mg/ml in DMSO (ultrasonic and warming and heat), Ethanol: 30 mg/ml, Ethanol:PBS (pH 7.2)(1:2): 0.3 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.3222 mL | 11.6112 mL | 23.2223 mL |
5 mM | 0.4644 mL | 2.3222 mL | 4.6445 mL |
10 mM | 0.2322 mL | 1.1611 mL | 2.3222 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet